ScholarIQanswers from OpenAlex & ORCID
Katherine B. Peters
ResearcherPublications, citations & collaboration network
Katherine B. Peters is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Katherine B. Peters have?
ScholarIQindexed works
Katherine B. Peters has 441 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Katherine B. Peters have?
ScholarIQcitation count
Katherine B. Peters has 9,682 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Katherine B. Peters?
ScholarIQh-index
Katherine B. Peters has an h-index of 46 in OpenAlex.
What is the i10-index of Katherine B. Peters?
ScholarIQi10-index
Katherine B. Peters has an i10-index of 122 in OpenAlex.
What is the ORCID of Katherine B. Peters?
ScholarIQorcid
The ORCID for Katherine B. Peters is on the source record.
What is the OpenAlex record for Katherine B. Peters?
ScholarIQopenalex
The OpenAlex for Katherine B. Peters is on the source record.
What are the most-cited papers on Katherine B. Peters?
ScholarIQmost cited works
Recurrent Glioblastoma Treated with Recombinant Poliovirus
Annick Desjardins, Matthias Gromeier, James E. Herndon, Nike Beaubier, Dani P. Bolognesi, Allan H. Friedman, Henry S. Friedman, Frances McSherry, Andrea Muscat, Smita K. Nair, Katherine B. Peters, Dina Randazzo, John H. Sampson, Gordana Vlahovic, W.T.A. Harrison, Roger E. McLendon, David M. Ashley, Darell D. Bigner
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma
Ingo K. Mellinghoff, Martin J. van den Bent, Deborah T. Blumenthal, Mehdi Touat, Katherine B. Peters, Jennifer Clarke, Joe Mendez, Shlomit Yust‐Katz, Liam Welsh, Warren Mason, François Ducray, Yoshie Umemura, Burt Nabors, Matthias Holdhoff, Andreas F. Hottinger, Yoshiki Arakawa, Juan Manuel Sepúlveda-Sánchez, Wolfgang Wick, Riccardo Soffietti, James Perry, Pierre Giglio, Macarena de la Fuente, Elizabeth A. Maher, Steven Schoenfeld, Dan Zhao, Shuchi S. Pandya, Lori Steelman, Islam Hassan, Patrick Y. Wen, Timothy F. Cloughesy
Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
Burt Nabors, Jana Portnow, Manmeet S. Ahluwalia, Joachim M. Baehring, Henry Brem, Steven Brem, Nicholas Butowski, Jian Campian, Stephen W. Clark, Andrew J. Fabiano, Peter Forsyth, Jona A. Hattangadi‐Gluth, Matthias Holdhoff, Craig Horbinski, Larry Junck, Thomas Kaley, Priya Kumthekar, Jay S. Loeffler, Maciej M. Mrugała, Seema Nagpal, Manjari Pandey, Ian F. Parney, Katherine B. Peters, Vinay K. Puduvalli, Ian Robins, Jason K. Rockhill, Chad G. Rusthoven, Nicole Shonka, Dennis C. Shrieve, Lode J. Swinnen, Stephanie E. Weiss, Patrick Y. Wen, Nicole E. Willmarth, Mary Anne Bergman, Susan Darlow
Rural–Urban Disparities in Cancer Outcomes: Opportunities for Future Research
Smita Bhatia, Wendy Landier, Electra D. Paskett, Katherine B. Peters, Janette K. Merrill, Jonathan Phillips, Raymond U. Osarogiagbon
Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial
Ingo K. Mellinghoff, Marta Peñas-Prado, Katherine B. Peters, Howard A. Burris, Elizabeth A. Maher, Filip Jankú, Gregory M. Coté, Macarena I. de la Fuente, Jennifer Clarke, Benjamin M. Ellingson, Saewon Chun, Robert J. Young, Hua Liu, Sung Choe, Min Lu, Kha Le, Islam Hassan, Lori Steelman, Shuchi S. Pandya, Timothy F. Cloughesy, Patrick Y. Wen